LexDanaLexDanabeta
Inventor

Xavier CHAUCHET

Inventor
CH

Overview

2→
Patents
2025–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
12,583,922Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof202612,448,444Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025–2026Patents assigned to NOVIMMUNE SA (2)· patent assignee history
2025–2026Based in CH· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVIMMUNE SA22025–2026
Locations
LocationPatentsSpan
CH22025–2026